While treatment with rhGH in normal mice increases body weight, lean body mass, and liver weight but does not increase hepatic expression and release of IGF1, suggesting IGF1 is not a reliable indicator of the biological effects of exogenous GH treatment in genetically and pharmacologically unmodified individuals (Yamauchi and Pessin, 1994
Liver fat, cardiovascular markers, and body composition continue to improve throughout this extended treatment period
For others, symptoms may start later but if left untreated most menopausal people will experience GSM
Maclean, P
METAOD004: A Phase IIa (double-blind, placebo-controlled, dose escalation) safety study with multiple daily doses (9, 27 or 54 mg AOD9604) administered orally (capsules) for seven days in 36 healthy clinically obese males presenting with a BMI 30 kg/m 2
Perhaps more research will make the connection clearer, but for now, check with your healthcare provider before altering your alcohol intake